Additional Details
-
A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550
University of PennsylvaniaPhiladelphia PA. 19104View Details -
A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550
CIC Mauricie Inc.Trois-Rivieres QC. G8T 7A1View Details -
A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550
Vancouver General HospitalVancouver BC. V5Z 1M9View Details -
A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550
Dr. Syed Anees Medicine Professional CorporationWindsor ON. N8X 1T3View Details -
A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550
IUCPQ (Laval University)Quebec G1V 4G5View Details -
A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550
Kelowna Respirology & Allergy ResearchKelowna BC. V1Y 3H5View Details -
A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550
Dr. Georges-L.-Dumont University Hospital CentreMoncton NB. E1C 2Z3View Details -
A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550
QEII Health Sciences CentreHalifax NS. B3H 3A7View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
UCLA Health Westwood Medical PlazaWestwood CA. 90095View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Tampa General Hospital Center of Research ExcellenceTampa FL. 33606View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Medical University of South CarolinaCharleston SC. 29425View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
UCSFSan Francisco CA. 94143View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
UC DavisSacramento CA. 95817View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Houston MethodistHouston TX. 77030View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Hartford HospitalHartford CT. 06102View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
UCLA WestwoodLos Angeles CA. 90095View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
NYU Langone Medical CenterNew York NY. 10016View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
University of UtahSalt Lake City UT. 84112View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Norton Pulmonary SpecialistsLouisville KY. 40241View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
University of MichiganAnn Arbor MI. 48109View Details